Ur Metser, MD, FRCPC
Dr. Ur Metser is the Division Head of Molecular Imaging at the Joint Department of Medical Imaging (UHN, Mount Sinai Hospital, and Women’s College Hospital), Site Director of Medical Imaging at the Princess Margaret Cancer Centre, and holds the position of Professor of Radiology, Department of Medical Imaging at the University of Toronto. He also chairs the Ontario Provincial Positron Emission Tomography Steering Committee at Cancer Care Ontario, responsible for the evidence-based introduction of PET in Ontario.
He is a fellow of the Royal College of Physicians (Canada) and an active member of multiple international professional societies, including the Radiological Society of North America and the Society of Nuclear Medicine, amongst others. Dr. Metser has published over 160 manuscripts in peer-reviewed journals, as well as multiple review articles, book chapters, and practice guidelines. His main clinical and research interests focus on novel molecular imaging probes, theranostics, hybrid imaging (PET/CT and PET/MR) for tumor detection, and the characterization and assessment of response to therapy with functional imaging.
Ur Metser, MD, FRCPC
Dr. Ur Metser is the Division Head of Molecular Imaging at the Joint Department of Medical Imaging (UHN, Mount Sinai Hospital, and Women’s College Hospital), Site Director of Medical Imaging at the Princess Margaret Cancer Centre, and holds the position of Professor of Radiology, Department of Medical Imaging at the University of Toronto. He also chairs the Ontario Provincial Positron Emission Tomography Steering Committee at Cancer Care Ontario, responsible for the evidence-based introduction of PET in Ontario.
He is a fellow of the Royal College of Physicians (Canada) and an active member of multiple international professional societies, including the Radiological Society of North America and the Society of Nuclear Medicine, amongst others. Dr. Metser has published over 160 manuscripts in peer-reviewed journals, as well as multiple review articles, book chapters, and practice guidelines. His main clinical and research interests focus on novel molecular imaging probes, theranostics, hybrid imaging (PET/CT and PET/MR) for tumor detection, and the characterization and assessment of response to therapy with functional imaging.